Skip to content

Clinical trials

Withdrawn Renal Insufficiency trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Renal Insufficiency Status: Withdrawn Country / region: United States Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20081
20092
20101
20111
20122
20162
20182
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital2
Midwestern University2
Eli Lilly and Company1
GE Healthcare1
Guerbet1
Henry Ford Health System1
NYU Langone Health1
Raymond T. Chung, MD1
Summa Health System1
University of Pennsylvania1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Renal Insufficiency14
Diabetes Mellitus3
Coronary Artery Disease2
Heart Failure2
Hepatitis C2
Pulmonary Disease, Chronic Obstructive2
Acute Coronary Syndrome1
Death1
Fibrosis1
Hyperphosphatemia1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.